222 related articles for article (PubMed ID: 31080076)
1. Parthenolide Covalently Targets and Inhibits Focal Adhesion Kinase in Breast Cancer Cells.
Berdan CA; Ho R; Lehtola HS; To M; Hu X; Huffman TR; Petri Y; Altobelli CR; Demeulenaere SG; Olzmann JA; Maimone TJ; Nomura DK
Cell Chem Biol; 2019 Jul; 26(7):1027-1035.e22. PubMed ID: 31080076
[TBL] [Abstract][Full Text] [Related]
2. The anti-inflammatory natural product parthenolide from the medicinal herb Feverfew directly binds to and inhibits IkappaB kinase.
Kwok BH; Koh B; Ndubuisi MI; Elofsson M; Crews CM
Chem Biol; 2001 Aug; 8(8):759-66. PubMed ID: 11514225
[TBL] [Abstract][Full Text] [Related]
3. Parthenolide induces apoptosis and cell cycle arrest of human 5637 bladder cancer cells in vitro.
Cheng G; Xie L
Molecules; 2011 Aug; 16(8):6758-68. PubMed ID: 21829151
[TBL] [Abstract][Full Text] [Related]
4. Feverfew extracts and the sesquiterpene lactone parthenolide inhibit intercellular adhesion molecule-1 expression in human synovial fibroblasts.
Piela-Smith TH; Liu X
Cell Immunol; 2001 May; 209(2):89-96. PubMed ID: 11446741
[TBL] [Abstract][Full Text] [Related]
5. Antiproliferative activities of parthenolide and golden feverfew extract against three human cancer cell lines.
Wu C; Chen F; Rushing JW; Wang X; Kim HJ; Huang G; Haley-Zitlin V; He G
J Med Food; 2006; 9(1):55-61. PubMed ID: 16579729
[TBL] [Abstract][Full Text] [Related]
6. Biosynthesis and localization of parthenolide in glandular trichomes of feverfew (Tanacetum parthenium L. Schulz Bip.).
Majdi M; Liu Q; Karimzadeh G; Malboobi MA; Beekwilder J; Cankar K; Vos Rd; Todorović S; Simonović A; Bouwmeester H
Phytochemistry; 2011 Oct; 72(14-15):1739-50. PubMed ID: 21620424
[TBL] [Abstract][Full Text] [Related]
7. Parthenolide induces apoptosis by activating the mitochondrial and death receptor pathways and inhibits FAK-mediated cell invasion.
Kwak SW; Park ES; Lee CS
Mol Cell Biochem; 2014 Jan; 385(1-2):133-44. PubMed ID: 24065392
[TBL] [Abstract][Full Text] [Related]
8. Parthenolide, a sesquiterpene lactone from the medical herb feverfew, shows anticancer activity against human melanoma cells in vitro.
Lesiak K; Koprowska K; Zalesna I; Nejc D; Düchler M; Czyz M
Melanoma Res; 2010 Feb; 20(1):21-34. PubMed ID: 19949351
[TBL] [Abstract][Full Text] [Related]
9. Comparison of anti-invasive activity of parthenolide and 3-isopropyl-2-methyl-4-methyleneisoxazolidin-5-one (MZ-6)--a new compound with α-methylene-γ-lactone motif--on two breast cancer cell lines.
Wyrębska A; Gach K; Szemraj J; Szewczyk K; Hrabec E; Koszuk J; Janecki T; Janecka A
Chem Biol Drug Des; 2012 Jan; 79(1):112-20. PubMed ID: 21992414
[TBL] [Abstract][Full Text] [Related]
10. Antileishmanial activity of parthenolide, a sesquiterpene lactone isolated from Tanacetum parthenium.
Tiuman TS; Ueda-Nakamura T; Garcia Cortez DA; Dias Filho BP; Morgado-Díaz JA; de Souza W; Nakamura CV
Antimicrob Agents Chemother; 2005 Jan; 49(1):176-82. PubMed ID: 15616293
[TBL] [Abstract][Full Text] [Related]
11. The natural sesquiterpene lactones arglabin, grosheimin, agracin, parthenolide, and estafiatin inhibit T cell receptor (TCR) activation.
Schepetkin IA; Kirpotina LN; Mitchell PT; Kishkentaeva АS; Shaimerdenova ZR; Atazhanova GA; Adekenov SM; Quinn MT
Phytochemistry; 2018 Feb; 146():36-46. PubMed ID: 29216473
[TBL] [Abstract][Full Text] [Related]
12. Parthenolide: from plant shoots to cancer roots.
Ghantous A; Sinjab A; Herceg Z; Darwiche N
Drug Discov Today; 2013 Sep; 18(17-18):894-905. PubMed ID: 23688583
[TBL] [Abstract][Full Text] [Related]
13. Microtubule-interfering activity of parthenolide.
Miglietta A; Bozzo F; Gabriel L; Bocca C
Chem Biol Interact; 2004 Oct; 149(2-3):165-73. PubMed ID: 15501437
[TBL] [Abstract][Full Text] [Related]
14. Parthenolide, a sesquiterpene lactone, expresses multiple anti-cancer and anti-inflammatory activities.
Mathema VB; Koh YS; Thakuri BC; Sillanpää M
Inflammation; 2012 Apr; 35(2):560-5. PubMed ID: 21603970
[TBL] [Abstract][Full Text] [Related]
15. Advances in chemistry and bioactivity of parthenolide.
Freund RRA; Gobrecht P; Fischer D; Arndt HD
Nat Prod Rep; 2020 Apr; 37(4):541-565. PubMed ID: 31763637
[TBL] [Abstract][Full Text] [Related]
16. Effect of parthenolide on growth and apoptosis regulatory genes of human cancer cell lines.
Al-Fatlawi AA; Al-Fatlawi AA; Irshad M; Rahisuddin ; Ahmad A
Pharm Biol; 2015 Jan; 53(1):104-9. PubMed ID: 25289524
[TBL] [Abstract][Full Text] [Related]
17. Antiproliferative activity of parthenolide against three human cancer cell lines and human umbilical vein endothelial cells.
Parada-Turska J; Paduch R; Majdan M; Kandefer-Szerszeń M; Rzeski W
Pharmacol Rep; 2007; 59(2):233-7. PubMed ID: 17556802
[TBL] [Abstract][Full Text] [Related]
18. Intra-specific variability of feverfew: correlations between parthenolide, morphological traits and seed origin.
Cutlan AR; Bonilla LE; Simon JE; Erwin JE
Planta Med; 2000 Oct; 66(7):612-7. PubMed ID: 11105564
[TBL] [Abstract][Full Text] [Related]
19. Parthenolide inhibits the proliferation and migration of cervical cancer cells via FAK/GSK3β pathway.
Huang L; Liu F; Liu X; Niu L; Sun L; Fang F; Ma K; Hu P
Cancer Chemother Pharmacol; 2024 Mar; 93(3):203-213. PubMed ID: 38141074
[TBL] [Abstract][Full Text] [Related]
20. Parthenolide content and bioactivity of feverfew (Tanacetum parthenium (L.) Schultz-Bip.). Estimation of commercial and authenticated feverfew products.
Heptinstall S; Awang DV; Dawson BA; Kindack D; Knight DW; May J
J Pharm Pharmacol; 1992 May; 44(5):391-5. PubMed ID: 1359053
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
